Your browser doesn't support javascript.
loading
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
Haydu, J Erika; Maron, Jenny S; Redd, Robert A; Gallagher, Kathleen M E; Fischinger, Stephanie; Barnes, Jeffrey A; Hochberg, Ephraim P; Johnson, P Connor; Takvorian, R W; Katsis, Katelin; Portman, Daneal; Ruiters, Jade; Sechio, Sidney; Devlin, Mary; Regan, Connor; Blumenthal, Kimberly G; Banerji, Aleena; Judd, Allen D; Scorsune, Krista J; McGree, Brianne M; Sherburne, Maryanne M; Lynch, Julia M; Weitzman, James I; Lei, Matthew; Kotton, Camille N; Dighe, Anand S; Maus, Marcela V; Alter, Galit; Abramson, Jeremy S; Soumerai, Jacob D.
Affiliation
  • Haydu JE; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Maron JS; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA.
  • Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.
  • Gallagher KME; Immune Monitoring Laboratory, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA; and.
  • Fischinger S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA.
  • Barnes JA; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Hochberg EP; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Johnson PC; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Takvorian RW; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Katsis K; Immune Monitoring Laboratory, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA; and.
  • Portman D; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Ruiters J; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Sechio S; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Devlin M; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Regan C; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Blumenthal KG; Department of Allergy and Immunology.
  • Banerji A; Department of Allergy and Immunology.
  • Judd AD; Department of Allergy and Immunology.
  • Scorsune KJ; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • McGree BM; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Sherburne MM; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Lynch JM; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Weitzman JI; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Lei M; Department of Pharmacy.
  • Kotton CN; Department of Infectious Diseases, and.
  • Dighe AS; Department of Pathology, Massachusetts General Hospital, Boston, MA.
  • Maus MV; Immune Monitoring Laboratory, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA; and.
  • Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA.
  • Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
  • Soumerai JD; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
Blood Adv ; 6(6): 1671-1683, 2022 03 22.
Article in En | MEDLINE | ID: mdl-35073571

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Type of study: Etiology_studies / Observational_studies Limits: Adult / Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Type of study: Etiology_studies / Observational_studies Limits: Adult / Humans Language: En Journal: Blood Adv Year: 2022 Document type: Article Affiliation country: